hydroxyindoleacetic acid has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwai, T | 1 |
| Ohnuki, T | 1 |
| Sasaki-Hamada, S | 1 |
| Saitoh, A | 1 |
| Sugiyama, A | 1 |
| Oka, J | 1 |
1 other study available for hydroxyindoleacetic acid and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Depressive | 2013 |